We are live on ! Find out more
ORIAU

Orion Biotech Opportunities Corp. Units
ORIAU

Delisted

ORIAU was delisted on the 25th of April, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of ORIAU yet.

ORIAU Hedge Fund Activity: Q2 2023 in Review

0 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Units (ORIAU) for Q2 2023, worth a combined $0 — down 100% from $15.6M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of ORIAU and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was JNE Partners, exiting entirely with an estimated $14.6M sold.

  • 0 institutional investors held Orion Biotech Opportunities Corp. Units (ORIAU) as of Q2 2023, down from 4 in Q1 2023.
  • Funds reported $0 of Orion Biotech Opportunities Corp. Units stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Orion Biotech Opportunities Corp. Units positions in Q2 2023 and 4 closed out, a net change of -4 holders.
  • The largest Orion Biotech Opportunities Corp. Units seller in Q2 2023 was JNE Partners, an estimated $14.6M sold.

Based on aggregated 13F filings for Q2 2023.